Berkeley, CA, United States of America

Hunghao Chu

This inventor holds 1 USPTO granted patent. Top assignee: Genedit, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hunghao Chu. Retrieved from https://idiyas.com/inventor/hunghao-chu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hunghao Chu - Innovator in RNA Technology

Introduction

Hunghao Chu is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of RNA technology, particularly through his innovative work on guide RNA.

Latest Patents

Hunghao Chu holds a patent for a structure-engineered guide RNA. This invention provides a modified guide RNA comprising an extension sequence, as well as related compositions and methods. His work in this area is crucial for advancements in genetic engineering and therapeutic applications.

Career Highlights

Hunghao Chu is currently associated with Genedit, Inc., where he continues to push the boundaries of RNA technology. His expertise and innovative mindset have positioned him as a key player in the field.

Collaborations

He collaborates with Kunwoo Lee, further enhancing the research and development efforts at Genedit, Inc. Their combined expertise contributes to the advancement of RNA-based technologies.

Conclusion

Hunghao Chu's contributions to RNA technology through his patent and work at Genedit, Inc. highlight his role as an influential inventor in the field. His innovative spirit continues to drive progress in genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…